ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy
Clinical trial NCT03712293 · COMPLETED
Trial details
- NCT number
- NCT03712293
- Sponsor
- InSightec
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-28
- Primary completion
- 2023-12-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.